CKD Bio Corporation, a part of Chong Kun Dang Holdings, is a leading global pharmaceutical company specializing in the manufacturing and supply of high-quality APIs and intermediates, including antibiotics, β-lactamase inhibitors, antidiabetics, and immunosuppressants. The company has a strong focus on fermentation technology and aims to provide top-grade products to over 80 countries worldwide.